Tracked shipping to South Africa with premium packaging for just R199 

Ship to
South Africa
0

My Account

  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional

menu

Select your country

Americas

Europe

Rest of the world

portada Emerging Drugs and Targets for Alzheimer's Disease: Volume 1: Beta-Amyloid (Drug Discovery)
Type
Physical Book
Publisher
Author
Year
2010
Language
English
Pages
342
Format
Hardcover
ISBN13
9781849730631
Edition No.
1
Categories

Emerging Drugs and Targets for Alzheimer's Disease: Volume 1: Beta-Amyloid (Drug Discovery)

Ana Martinez (Author) · Royal Society Of Chemistry · Hardcover

Emerging Drugs and Targets for Alzheimer's Disease: Volume 1: Beta-Amyloid (Drug Discovery) - ana martinez

Cheaper New Book Imported to South Africa
Delivery: 02 Sep - 10 Sep Shipping: 13 to 14 business days.
R 3,493
Faster New Book Imported to South Africa
Delivery: 19 Aug - 27 Aug Shipping: 4 to 5 business days.
R 4,408
R 3,493

Choose the list to add your product or create one New List

Go to My Wishlists
Calculate shipping cost

Synopsis "Emerging Drugs and Targets for Alzheimer's Disease: Volume 1: Beta-Amyloid (Drug Discovery) "

Alzheimer's disease is the most prevalent neurodegenerative disorder in the elderly. A recent study from the Bloomberg School of Public Health recently estimated that over 26 million people were living with the disease in 2006 and that the global prevalence of the disease will grow to 106 million by 2050. By that time, 43 per cent of those living with the disease will need high-level care, equivalent to that of a nursing home. However, even if modest advances in preventing or delaying the disease's progression were made, it could have a huge impact on global public health. According to this study, interventions that could delay the onset of the disease by as little as one year would reduce the prevalence of the disease by 12 million fewer cases in 2050. These figures reinforce how important it is to find an effective intervention for Alzheimer's disease. Emerging Drugs and Targets for Alzheimer's Disease collects some of the most outstanding examples of new drugs currently under pharmaceutical development or new targets in the validation process that will reach the Alzheimer's drug market over the next few years as disease modifying drugs. Written by a team of distinguished experts, these volumes are an essential resource for scientists in the pharmaceutical and biotechnology industries and academics working in the neurosciences field.

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

Is the book original?

All books in our catalog are Original.

In what language is the book written?

The book is written in English.

What is the format of this book?

The binding of this edition is Hardcover.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews